COVID-19 in Liver Transplant Patients: A University Hospital Experience
Description
CONCLUSIONS: The course of COVID-19 in liver recipients without any underlying disease other than transplantation is not different from that in the healthy population. Immunosuppressive therapy was continued in patients with the disease, and two